| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 25-07-2018 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 1.87% As on (30-03-2026) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 6,500.11 Cr As on 30-04-2026(Source:AMFI) |
| Turn over: 0.58% | Exit Load: 1% on or before 15D, Nil after 15D |
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
| Standard Deviation | 16.91 |
| Sharpe Ratio | 1.2 |
| Alpha | 4.54 |
| Beta | 0.92 |
| Yield to Maturity | - |
| Average Maturity | - |
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Small Cap
39.98%
Others
0.17%
Large Cap
46.75%
Mid Cap
13.1%